Net profit of Pfizer rose 6.30% to Rs 158.35 crore in the quarter ended September 2024 as against Rs 148.96 crore during the previous quarter ended September 2023. Sales rose 2.33% to Rs 588.59 crore in the quarter ended September 2024 as against Rs 575.21 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 588.59 | 575.21 | 2 |
| OPM % | 32.15 | 31.75 | - |
| PBDT | 230.22 | 215.95 | 7 |
| PBT | 215.23 | 200.52 | 7 |
| NP | 158.35 | 148.96 | 6 |